ClinicalTrials.govpublic full text
A Study to Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS)
amyotrophic lateral sclerosis, familial amyotrophic lateral sclerosis, sporadic amyotrophic lateral sclerosis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 846966
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.